Aggressive uterine sarcoma with rhabdoid features:: Diagnosis by peritoneal fluid cytology and absence of INI1 gene mutation

被引:15
作者
Knapik, J
Yachnis, AT
Ripley, D
Biegel, JA
Rathor, S
Hardt, NS
Talerman, A
Wilkinson, EJ
机构
[1] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Dept Immunol, Gainesville, FL 32610 USA
[3] Univ Florida, Coll Med, Dept Lab Med, Gainesville, FL 32610 USA
[4] Univ Florida, Coll Med, Dept Obstet & Gynecol, Gainesville, FL 32610 USA
[5] Thomas Jefferson Med Coll, Dept Pathol, Philadelphia, PA USA
[6] Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA
关键词
intermediate filaments; fluorescence in situ hybridization;
D O I
10.1053/hupa.2001.26476
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We report a primary uterine sarcoma with classic histologic, immunohistochemical, and ultrastructural features of a malignant extrarenal rhabdoid tumor (MERT). It arose in a 71-year-old woman who presented with postmenopausal bleeding, ascites, and a right pelvic mass. Malignant cells with rhabdoid morphology were identified by cytologic examination of the peritoneal fluid. Exploratory laparotomy revealed a 10-cm right adnexal mass and disseminated peritoneal tumor. Pathologic study showed diffuse expansion of the endometrial stroma by rhabdoid-like cells with transmural infiltration of the myometrium and extensive involvement of uterine serosa and right ovary by tumor. Neoplastic cells were immunoreactive for vimentin, cytokeratin, and epithelial membrane antigen, and cytoplasmic whorls of intermediate filaments were observed by electron microscopy. Fluorescence in situ hybridization (FISH) studies with chromosome 22-specific probes showed no loss of the INI1 gene, and no coding sequence mutation was identified. HUM PATHOL 32: 884-886. (C) 2001 by W.B. Saunders Company.
引用
收藏
页码:884 / 886
页数:3
相关论文
共 17 条
[1]   Malignant mixed Mullerian tumor with rhabdoid features: A report of two cases and a review of the literature [J].
Baschinsky, DY ;
Niemann, TH ;
Eaton, LA ;
Frankel, WL .
GYNECOLOGIC ONCOLOGY, 1999, 73 (01) :145-150
[2]  
BECKWITH JB, 1978, CANCER-AM CANCER SOC, V41, P1937, DOI 10.1002/1097-0142(197805)41:5<1937::AID-CNCR2820410538>3.0.CO
[3]  
2-U
[4]  
Biegel JA, 2000, GENE CHROMOSOME CANC, V28, P31, DOI 10.1002/(SICI)1098-2264(200005)28:1<31::AID-GCC4>3.0.CO
[5]  
2-Y
[6]  
Biegel JA, 1999, CANCER RES, V59, P74
[7]   MALIGNANT RHABDOID TUMOR OF THE UTERUS - AN IMMUNOHISTOCHEMICAL AND ULTRASTRUCTURAL-STUDY [J].
CATTANI, MG ;
VIALE, G ;
SANTINI, D ;
MARTINELLI, GN .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1992, 420 (05) :459-462
[8]   MALIGNANT RHABDOID TUMOR OF THE UTERUS [J].
CHO, KR ;
ROSENSHEIN, NB ;
EPSTEIN, JI .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1989, 8 (04) :381-387
[9]   ENDOMETRIAL STROMAL SARCOMA WITH RHABDOID DIFFERENTIATION [J].
FITKO, R ;
BRAINER, J ;
SCHINK, JC ;
AUGUST, CZ .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1990, 9 (04) :379-381
[10]   Malignant rhabdoid tumor of the uterine corpus [J].
Hsueh, S ;
Chang, TC .
GYNECOLOGIC ONCOLOGY, 1996, 61 (01) :142-146